What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Disease
His main research concerns Internal medicine, Gastroenterology, Cirrhosis, Fatty liver and Nonalcoholic fatty liver disease.
His research on Internal medicine often connects related topics like Endocrinology.
Arun J. Sanyal interconnects Liver biopsy, Immunology, Model for End-Stage Liver Disease and Hepatitis C virus in the investigation of issues within Gastroenterology.
His Cirrhosis research is multidisciplinary, incorporating elements of Liver disease, Surgery, Hepatocellular carcinoma and Intensive care medicine.
His Fatty liver study integrates concerns from other disciplines, such as Apoptosis, Cancer research, Obesity and microRNA.
His research in Nonalcoholic fatty liver disease intersects with topics in Odds ratio, Hepatology and Primary biliary cirrhosis.
His most cited work include:
- The Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology (1133 citations)
- Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. (465 citations)
- Altered profile of human gut microbiome is associated with cirrhosis and its complications (460 citations)
What are the main themes of his work throughout his whole career to date?
Arun J. Sanyal mainly focuses on Internal medicine, Gastroenterology, Cirrhosis, Nonalcoholic fatty liver disease and Fatty liver.
Arun J. Sanyal regularly links together related areas like Endocrinology in his Internal medicine studies.
His Gastroenterology research integrates issues from Placebo, Liver transplantation, Liver biopsy and Hepatitis C.
In his research, Transjugular intrahepatic portosystemic shunt is intimately related to Surgery, which falls under the overarching field of Cirrhosis.
The various areas that Arun J. Sanyal examines in his Nonalcoholic fatty liver disease study include Steatosis, Metabolic syndrome, Hepatology and Insulin resistance.
His Fatty liver study results in a more complete grasp of Disease.
He most often published in these fields:
- Internal medicine (64.77%)
- Gastroenterology (41.78%)
- Cirrhosis (25.09%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (64.77%)
- Gastroenterology (41.78%)
- Nonalcoholic fatty liver disease (17.92%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Steatohepatitis and Cirrhosis are his primary areas of study.
He studied Internal medicine and Endocrinology that intersect with Agonist.
His studies in Gastroenterology integrate themes in fields like Nonalcoholic steatohepatitis, Rifaximin, Randomized controlled trial, Placebo and Obeticholic acid.
His research integrates issues of Chronic liver disease, Steatosis, Metabolic syndrome and Insulin resistance in his study of Nonalcoholic fatty liver disease.
The Steatohepatitis study combines topics in areas such as Non alcoholic and Liver biopsy.
His Cirrhosis research includes elements of Hepatocellular carcinoma, Clinical trial, Hepatology and Liver transplantation.
Between 2017 and 2021, his most popular works were:
- Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030 (328 citations)
- MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. (315 citations)
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial. (282 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Arun J. Sanyal mostly deals with Internal medicine, Nonalcoholic fatty liver disease, Gastroenterology, Steatohepatitis and Fatty liver.
His Internal medicine study combines topics in areas such as Placebo and Endocrinology.
His Nonalcoholic fatty liver disease research incorporates elements of Interquartile range, Methylation, Cirrhosis, Hepatic fibrosis and Hepatology.
The study incorporates disciplines such as Body mass index and Liver disease in addition to Cirrhosis.
Arun J. Sanyal combines subjects such as Nonalcoholic steatohepatitis, Biopsy, Placebo-controlled study and Confidence interval with his study of Gastroenterology.
His Fatty liver study incorporates themes from Chronic liver disease, Prospective cohort study and Obesity, Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
